Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 0 | 0 | 38 | 38 | 0 |
| Gross Profit | N/A | N/A | N/A | 38 | N/A |
| Operating Expenses | 0 | 4,889 | 0 | 1,189 | 0 |
| Operating Income | N/A | -4,889 | -3,758 | -1,151 | N/A |
| Other Income | 0 | 1,410 | -97 | 971 | 0 |
| Pre-tax Income | 0 | -3,479 | -3,855 | -181 | 0 |
| Income Tax | N/A | -400 | N/A | N/A | N/A |
| Net Income Continuous | N/A | -3,079 | N/A | -181 | N/A |
| Net Income | $N/A | $-3,079 | $N/A | $-181 | $N/A |
| EPS Basic Total Ops | N/A | -120.00 | -152.00 | -16.00 | N/A |
| EPS Basic Continuous Ops | N/A | -120.63 | N/A | -7.23 | N/A |
| EPS Diluted Total Ops | N/A | -120.00 | -152.00 | -16.00 | N/A |
| EPS Diluted Continuous Ops | N/A | -120.63 | N/A | -7.23 | N/A |
| EBITDA(a) | $N/A | $-4,808 | $67 | $-1,151 | $N/A |